Friday - July 31, 2026
Greenberg Traurig Represents Ashlins Pharmaceuticals in Strategic Global Life Sciences Licensing Transaction
July 30, 2026
MIAMI, Florida, July 30 [Category: BizLaw/Legal] -- Greenberg Traurig, a law firm, issued the following news release:

* * *

Greenberg Traurig Represents Ashlins Pharmaceuticals in Strategic Global Life Sciences Licensing Transaction

*

NEW YORK - July 30, 2026 - Global law firm Greenberg Traurig, LLP advised Ashlins Ocular Pharmaceuticals, Inc. (Ashlins), a wholly owned subsidiary of Ashlins Pharmaceuticals, on its exclusive license and supply a . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products